Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumour cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10 per cent to 30 per cent of treated patients experience long-term improvement.
A recent research has identified a unique genetic signature among subsets of infiltrating T cells of different types of cancer after analyzing data from a public repository, CD4-T, CD8-T cells, and Treg.
Washington [US], September 2 (ANI): Researchers have published results that show encouraging therapeutic options for patients with blood cancer and multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two
Washington [US], September 2 (ANI): The treatment of various tumours has been transformed by cell-based immunotherapy, often known as CAR-T cell therapy. In order to target and combat specific forms of leukaemia and lymphoma, the treatment employs genetically engineered T cells. While it has
Gothenburg [Sweden], July 22 (ANI): Shortly after infection, patients infected with SARS-CoV-2 develop protective immune responses mediated by virus-specific T cells and antibodies. However, there is concern that immunity does not last, which could result in severe COVID-19 infection upon re
Washington [US], July 2 (ANI): During a recent study, researchers identified a new mechanism that teaches immune cells-in-training to spare the body's own tissues while attacking pathogens.
Washington [US], June 30 (ANI): Researchers have gained ground in understanding unique immune cells equipped to remember the identities of malicious invaders. The researchers developed a new atlas that describes tissue-resident memory T cells in diverse tissue settings, boosting the prospect
California [US], June 30 (ANI): According to a new study, CD8+ T cells which are activated in response to infections and tumours and are able to recall the names of harmful invaders, are receiving more attention from researchers studying how the human immune system reacts to pathogens and ca
Washington [US], June 28 (ANI): Researchers identify new mechanism that teaches immune cells-in-training to spare the body's own tissues while attacking pathogens. As part of this early education, specialized thymus cells 'pose' as different tissues, teaching the immune system how to recogni
Los Angeles [US], June 19 (ANI): According to the researchers at the University of Pennsylvania, synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo or radiation.
Los Angeles [US], June 19 (ANI): According to UCLA scientists working with Stanford and University of Pennsylvania experts, a synthetic IL-9 receptor permits cancer-fighting T cells to accomplish their job without the usage of chemo or radiation.
Los Angeles [US], June 17 (ANI): According to a team led by UCLA in collaboration with scientists from Stanford and the University of Pennsylvania, has demonstrated that a synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo or radiation.